Tumor Microenvironment Remodeling‐Mediated Sequential Drug Delivery Potentiates Treatment Efficacy
Advanced Materials · 2024
DOI: 10.1002/adma.202312493 ↗Kurz gefasst
Fachartikel in der Zeitschrift Advanced Materials, 2024. Verfasst von Yajun Xu und 10 weiteren Autor:innen. Beteiligte Einrichtung: Key Laboratory of Polymer Ecomaterials, Changchun Institute of Applied Chemistry, Chinese Academy of Sciences, Changchun, 130022, China. Hauptthemen laut MEDLINE: Tumor Microenvironment. Die Arbeit wurde bisher 45-mal zitiert (Crossref) und nennt 34 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Jilin Provincial International Cooperation Key Laboratory of Biomedical Polymers, Youth Innovation Promotion Association of the Chinese Academy of Sciences.
Abstract (Originalsprache)
Toll‐like receptor 7/8 agonists, such as imidazoquinolines (IMDQs), are promising for the de novo priming of antitumor immunity. However, their systemic administration is severely limited due to the off‐target toxicity. Here, this work describes a sequential drug delivery strategy. The formulation is composed of two sequential modules: a tumor microenvironment remodeling nanocarrier (poly( l ‐glutamic acid)‐ graft‐ methoxy poly(ethylene glycol)/combretastatin A4, termed CA4‐NPs) and an immunotherapy nanocarrier (apcitide peptide‐decorated poly( l ‐glutamic acid)‐ graft ‐IMDQ‐N 3 conjugate, termed apcitide‐PLG‐IMDQ‐N 3 ). CA4‐NPs, as a vascular disrupting agent, are utilized to remodel the tumor microenvironment for enhancing tumor coagulation and hypoxia. Subsequently, the apcitide‐PLG‐IMDQ‐N 3 could identify and target tumor coagulation through the binding of surface apcitide peptide to the GPIIb‐IIIa on activated platelets. Afterward, IMDQ is activated selectively through the conversion of “‐N 3 ” to “‐NH 2 ” in the presence of hypoxia. The biodistribution results confirm their high tumor uptake of activated IMDQ (22.66%ID/g). By augmenting the priming and immunologic memory of tumor‐specific CD8 + T cells, 4T1 and CT26 tumors with a size of ≈500 mm 3 are eradicated without recurrence in mouse models.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Key Laboratory of Polymer Ecomaterials, Changchun Institute of Applied Chemistry, Chinese Academy of Sciences, Changchun, 130022, China.
- School of Applied Chemistry and Engineering, University of Science and Technology of China, Hefei, 230026, China.
- Jilin Biomedical Polymers Engineering Laboratory, Changchun, 130022, China.
- National Key Laboratory of Advanced Drug Delivery and Release Systems, College of Pharmaceutical Sciences, Zhejiang University, Hangzhou, 310058, China.
- Jinhua Institute of Zhejiang University, Jinhua, 321037, China.
- Key Laboratory for Advanced Drug Delivery Systems of Zhejiang Provincial, College of Pharmaceutical Sciences, Zhejiang University, Hangzhou, 310058, China.
ORCID-Profile: Zhen Gu
Förderung
- National Natural Science Foundation of China
- Jilin Provincial International Cooperation Key Laboratory of Biomedical Polymers
- Youth Innovation Promotion Association of the Chinese Academy of Sciences
- Ministry of Science and Technology of the People's Republic of China
Zitieren
APA
Xu, Y., Lv, J., Liu, F., Wang, J., Liu, Y., Kong, C., Li, Y., Shen, N., Gu, Z., Tang, Z., & Chen, X. (2024). Tumor Microenvironment Remodeling‐Mediated Sequential Drug Delivery Potentiates Treatment Efficacy. Advanced Materials. https://doi.org/10.1002/adma.202312493
Vancouver
Xu Y, Lv J, Liu F, Wang J, Liu Y, Kong C, et al. Tumor Microenvironment Remodeling‐Mediated Sequential Drug Delivery Potentiates Treatment Efficacy. Advanced Materials. 2024. doi:10.1002/adma.202312493
BibTeX
@article{Xu2024,
author = {Xu, Yajun and Lv, Jianlin and Liu, Fuyao and Wang, Jinqiang and Liu, Ya and Kong, Chaoying and Li, Yanran and Shen, Na and Gu, Zhen and Tang, Zhaohui and Chen, Xuesi},
title = {Tumor Microenvironment Remodeling‐Mediated Sequential Drug Delivery Potentiates Treatment Efficacy},
journal = {Advanced Materials},
year = {2024},
doi = {10.1002/adma.202312493}
}
EUVIMED